Cargando…
Development of a Drosophila melanogaster spliceosensor system for in vivo high-throughput screening in myotonic dystrophy type 1
Alternative splicing of pre-mRNAs is an important mechanism that regulates cellular function in higher eukaryotes. A growing number of human genetic diseases involve splicing defects that are directly connected to their pathology. In myotonic dystrophy type 1 (DM1), several clinical manifestations h...
Autores principales: | García-Alcover, Irma, Colonques-Bellmunt, Jordi, Garijo, Raquel, Tormo, José R., Artero, Rubén, Álvarez-Abril, Mari Carmen, López Castel, Arturo, Pérez-Alonso, Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Limited
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4213733/ https://www.ncbi.nlm.nih.gov/pubmed/25239918 http://dx.doi.org/10.1242/dmm.016592 |
Ejemplares similares
-
Natural Compound Boldine Lessens Myotonic Dystrophy Type 1 Phenotypes in DM1 Drosophila Models, Patient-Derived Cell Lines, and HSA(LR) Mice
por: Álvarez-Abril, Mari Carmen, et al.
Publicado: (2023) -
(CCUG)(n) RNA toxicity in a Drosophila model of myotonic dystrophy type 2 (DM2) activates apoptosis
por: Yenigun, Vildan Betul, et al.
Publicado: (2017) -
MicroRNA-Based Therapeutic Perspectives in Myotonic Dystrophy
por: López Castel, Arturo, et al.
Publicado: (2019) -
Myotonic dystrophy type 1 drug development: A pipeline toward the market
por: Pascual-Gilabert, Marta, et al.
Publicado: (2021) -
Modeling of Myotonic Dystrophy Cardiac Phenotypes in Drosophila
por: Chakraborty, Mouli, et al.
Publicado: (2018)